Evidence map›Paper›PMID 40799623›Full record

ArticleSynthetic biology (Oxford, England)2025

Construction of a syntrophic

Barbora Burýšková, Jesús Miró-Bueno, Barbora Popelářová, Barbora Gavendová, Ángel Goñi-Moreno, Pavel Dvořák

Abstract read
In one paragraph

Article in Synthetic biology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Barbora BurýškováDepartment of Experimental Biology (Section of Microbiology), Faculty of Science, Masaryk University, Kamenice 753/5, Brno 62500, Czech Republic.ORCID https://orcid.org/0000-0002-9945-1893
Jesús Miró-BuenoSystems Biology Department, Centro Nacional de Biotecnología, CSIC, Darwin 3, Madrid 28049, Spain.ORCID https://orcid.org/0000-0002-4543-0616
Barbora PopelářováDepartment of Experimental Biology (Section of Microbiology), Faculty of Science, Masaryk University, Kamenice 753/5, Brno 62500, Czech Republic.
Barbora GavendováDepartment of Experimental Biology (Section of Microbiology), Faculty of Science, Masaryk University, Kamenice 753/5, Brno 62500, Czech Republic.
Ángel Goñi-MorenoSystems Biology Department, Centro Nacional de Biotecnología, CSIC, Darwin 3, Madrid 28049, Spain.ORCID https://orcid.org/0000-0002-2097-2507
Pavel DvořákDepartment of Experimental Biology (Section of Microbiology), Faculty of Science, Masaryk University, Kamenice 753/5, Brno 62500, Czech Republic.ORCID https://orcid.org/0000-0002-3215-4763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic microbial consortia can leverage their expanded enzymatic reach to tackle biotechnological challenges too complex for single strains, such as biosynthesis of complex secondary metabolites or waste plant biomass degradation and valorisation. The benefit of metabolic cooperation comes with a catch-installing stable interactions between consortium members. Here, we established a mutualistic relationship in the synthetic consortium of

Indexed as

disaccharidesmathematical modelPseudomonas putidareciprocal substrate processingsynthetic consortium

Identifiers

PMID40799623
PMCPMC12341930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.